Last reviewed · How we verify
HuHuangLianzonggan capsule — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
HuHuangLianzonggan capsule (HuHuangLianzonggan capsule) — Tasly Pharmaceutical Group Co., Ltd.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| HuHuangLianzonggan capsule TARGET | HuHuangLianzonggan capsule | Tasly Pharmaceutical Group Co., Ltd | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- HuHuangLianzonggan capsule CI watch — RSS
- HuHuangLianzonggan capsule CI watch — Atom
- HuHuangLianzonggan capsule CI watch — JSON
- HuHuangLianzonggan capsule alone — RSS
Cite this brief
Drug Landscape (2026). HuHuangLianzonggan capsule — Competitive Intelligence Brief. https://druglandscape.com/ci/huhuanglianzonggan-capsule. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab